PROM1 and colorectal carcinoma: In our experimental system, purified CD133+ CRC cells were able to be passaged under sphere-forming assay for at least three generations, and more significantly, CD133+ CRC cells highly enriched for tumorigenic cells in transplantation assay, suggesting that CD133+ CRC cells may enrich for putative CSCs.